Circulating tumour cells and tumour biomarkers in functional midgut neuroendocrine tumours

CALM‐NET was a phase IV exploratory study in the UK that aimed to evaluate if the presence of circulating tumour cells (CTCs) at baseline predicted symptomatic response in patients with midgut neuroendocrine tumours (NETs) treated with lanreotide autogel (LAN). Adults with functional, well/moderatel...

Descripción completa

Detalles Bibliográficos
Autores principales: Meyer, Tim, Caplin, Martyn, Khan, Mohid S., Toumpanakis, Christos, Shetty, Shishir, Ramage, John K., Houchard, Aude, Higgs, Kate, Shah, Tahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Translational and Clinical Neuroendocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285714/
https://www.ncbi.nlm.nih.gov/pubmed/35132704
http://dx.doi.org/10.1111/jne.13096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9285714/
https://www.ncbi.nlm.nih.gov/pubmed/35132704
http://dx.doi.org/10.1111/jne.13096

Ejemplares similares